Company Contact Information Consumers: 866-770-3024 alvogensmb@continuumindia.com Press: Alvogenpress@mercuryllc.com MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ — Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.